Alternatives to Pepticom

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

AI-powered platform for designing novel molecular structures for new medicines.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Compressing biology to develop the next generation of therapies.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Vivodyne is developing advanced AI models for drug discovery and development.

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Synthetic biology startup optimizing gene expression for food and biotech applications.

AI-enabled technology for cell biology research and biopharma development.

Tech.Bio company advancing mRNA discovery with AI and its mRNA Lightning platform.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-powered platform for antibody discovery and development to create new medicines.

Develops precision proteins for impact nutrition using proteomics and bioinformatics.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

AI-powered platform accelerating biological research and drug discovery.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

Developing novel diagnostics to predict patient response to immunotherapy.

Israeli biotech research institute and technology accelerator focused on molecular biology.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Develops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

AI-powered diagnostic imaging for early detection of diabetic retinopathy.

AI platform for clinical trial data analysis to improve patient outcomes.

Transforming healthcare by turning scientific fiction into scientific facts.

AI-driven digital twin of embryo development for cell-based therapies.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

AI-powered platform for accelerating phylogenetic analysis and evolutionary biology research.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Developing advanced bio-integrated devices for enhanced medical diagnostics and therapeutics.

Life science company pioneering drug discovery with AI and advanced technologies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

AI-powered drug discovery and development platform for biologics.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions.

AI-powered care coordination platform for faster diagnosis and treatment of critical conditions.